← Back to catalogue

LEGOO Temporary Endovascular Occluder

FDA PMA

Class III (US FDA PMA)

PMA P110003

by Genzyme Corp.

Identity

Trade Name
LEGOO FDA PMA
Generic Name
Occluder, internal vessel, temporary FDA PMA

Identifiers

PMA Number
P110003 FDA PMA
FDA Product Code
OBC FDA PMA

Classification

Device Class
Class III FDA PMA
Advisory Committee
Cardiovascular FDA PMA
FDA Decision
APWD FDA PMA

The LEGOO Temporary Endovascular Occluder is a Class III device classified as an internal vessel occluder designed for temporary occlusion of blood vessels below the neck. It is intended for use in vessels up to 4 mm in diameter, providing controlled vascular closure during interventional procedures.

This device is supplied sterile and is intended for single-use. It is regulated under an FDA Premarket Approval (PMA) with approval number P110003, filed under product code OBC for cardiovascular applications. Storage and handling must comply with sterile medical device protocols to ensure integrity prior to use.

Frequently asked questions

What types of blood vessels is the LEGOO Temporary Endovascular Occluder designed to temporarily close, and what size vessels can it handle?

The LEGOO is specifically designed for temporary occlusion of blood vessels located below the neck. It is intended for use in vessels with a diameter up to 4 mm, providing controlled closure during interventional procedures.

Is the LEGOO Temporary Endovascular Occluder meant for repeated use, or is it single-use only?

The LEGOO is supplied sterile and explicitly intended for single-use only. This ensures patient safety and maintains device integrity, as reuse could compromise sterility and performance.

How should the LEGOO Temporary Endovascular Occluder be stored to maintain its sterility and functionality?

The LEGOO must be stored and handled according to sterile medical device protocols to preserve its integrity before use. This includes keeping it in its original packaging and following manufacturer guidelines to prevent contamination.

What regulatory pathway does the LEGOO Temporary Endovascular Occluder follow, and what approval number is associated with it?

The LEGOO follows the FDA Premarket Approval (PMA) pathway, which is required for Class III devices. It holds approval number P110003, filed under product code OBC for cardiovascular applications, reflecting its classification as an internal vessel occluder.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Active

FDA_PMA

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Genzyme Corp.

Sources (1)

  • FDA PMA P110003 24 fields · synced Sep 18, 2026